Literature DB >> 25044190

Why providers transfuse blood products outside recommended guidelines in spite of integrated electronic best practice alerts.

Jonathan H Chen1, Daniel Z Fang, Lawrence Tim Goodnough, Kambria H Evans, Martina Lee Porter, Lisa Shieh.   

Abstract

BACKGROUND: Best practice alerts (BPAs) provide clinical decision support (CDS) at the point of care to reduce unnecessary blood product transfusions, yet substantial transfusions continue outside of recommended guidelines.
OBJECTIVE: To understand why providers order blood transfusions outside of recommended guidelines despite interruptive alerts.
DESIGN: Retrospective review.
SETTING: Tertiary care hospital. PARTICIPANTS: Inpatient healthcare providers. INTERVENTION: Provider-BPA interaction data were collected from January 2011 to August 2012 from the hospital electronic medical record. MEASUREMENTS: Provider (free-text) responses to blood transfusion BPA prompts were independently reviewed and categorized by 2 licensed physicians, with agreement assessed by χ(2) analysis and kappa scoring.
RESULTS: Rationale for overriding blood transfusion BPAs was highly diverse, acute bleeding being the most common (>34%), followed by protocolized behaviors on specialty services (up to 26%), to "symptomatic" anemia (11%-12%). Many providers transfused in anticipation of surgical or procedural intervention (10%-15%) or imminent hospital discharge (2%-5%). Resident physicians represented the majority (55%) of providers interacting with BPAs.
CONCLUSION: Providers interacting with BPAs (primarily residents and midlevel providers) often do not have the negotiating power to change ordering behavior. Protocolized behaviors, unlikely to be influenced by BPAs, are among the most commonly cited reasons for transfusing outside of guidelines. Symptomatic anemia is a common, albeit subjective, indication cited for blood transfusion. With a wide swath of individually uncommon rationales for transfusion behavior, secondary use of electronic medical record databases and integrated CDS tools are important to efficiently analyze common practice behaviors.
© 2014 Society of Hospital Medicine.

Entities:  

Mesh:

Year:  2014        PMID: 25044190     DOI: 10.1002/jhm.2236

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  7 in total

1.  DYNAMICALLY EVOLVING CLINICAL PRACTICES AND IMPLICATIONS FOR PREDICTING MEDICAL DECISIONS.

Authors:  Jonathan H Chen; Mary K Goldstein; Steven M Asch; Russ B Altman
Journal:  Pac Symp Biocomput       Date:  2016

2.  Clinical decision support and improved blood use in patient blood management.

Authors:  Lawrence Tim Goodnough; Marie A Hollenhorst
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Decaying relevance of clinical data towards future decisions in data-driven inpatient clinical order sets.

Authors:  Jonathan H Chen; Muthuraman Alagappan; Mary K Goldstein; Steven M Asch; Russ B Altman
Journal:  Int J Med Inform       Date:  2017-03-18       Impact factor: 4.046

4.  Developing an Ophthalmology Clinical Decision Support System to Identify Patients for Low Vision Rehabilitation.

Authors:  Xinxing Guo; Bonnielin K Swenor; Kerry Smith; Michael V Boland; Judith E Goldstein
Journal:  Transl Vis Sci Technol       Date:  2021-03-01       Impact factor: 3.283

5.  Does training make a difference? Proficiency training in transfusion guidelines and its effect on red blood cell administration.

Authors:  Svetlana Daichman; Daniel Ostrovsky; Jacob Dreiher; Oleg Pikovsky
Journal:  Transfusion       Date:  2022-04-01       Impact factor: 3.337

6.  Lessons learned from the COVID-19 pandemic blood supply crisis.

Authors:  Patrick T McGann; Angela C Weyand
Journal:  J Hosp Med       Date:  2022-06-21       Impact factor: 2.899

7.  Prevalence and Predictability of Low-Yield Inpatient Laboratory Diagnostic Tests.

Authors:  Song Xu; Jason Hom; Santhosh Balasubramanian; Lee F Schroeder; Nader Najafi; Shivaal Roy; Jonathan H Chen
Journal:  JAMA Netw Open       Date:  2019-09-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.